Caregiver burden, health utilities, and institutional service costs among community-dwelling patients with Alzheimer disease.

Alzheimer Disease and Associated Disorders
Edward Alan MillerLon S Schneider

Abstract

This study examined the moderating effect of caregiver burden on the relationship between patients' health status and institutional costs in Alzheimer disease (AD). Data were obtained on whether 421 community-dwelling patients with AD in the CATIE-AD trial received institutional services in the month preceding baseline and at 3-month, 6-month, and 9-month follow-up. All participants had a caregiver who lived with or visited them regularly. Outcome variables include hospital, nursing home, residential, and combined institutional costs. Mixed models were employed to estimate the interaction of Health Utility Index (HUI)-III scores (a health status measure) and 5 measures of caregiver burden. Wherever significant, results indicate that greater caregiver burden weakens the inverse relationship between health utilities and institutional costs, leading to greater costs than would be expected at a given level of health. Altogether 45.0% of the models (9/20) showed this effect (positive coefficient on the burden-HUI interaction term). Interventions to support caregivers should be based on caregiver burden, regardless of care recipient health status, for even seemingly manageable patients may be at heightened risk for institutionalizati...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Sep 1, 1992·Journal of the American Geriatrics Society·B M DraperF Ehrlich
Jul 1, 1991·Psychosomatic Medicine·J K Kiecolt-GlaserR Glaser
Jan 1, 1992·Journal of Clinical Epidemiology·M BaumgartenS Gauthier
Dec 1, 1991·Psychology and Aging·R Schulz, G M Williamson
Aug 1, 1984·The British Journal of Psychiatry : the Journal of Mental Science·C J GilleardK Gledhill
Dec 1, 1980·The Gerontologist·S H ZaritJ Bach-Peterson
Jan 23, 1999·Health Affairs·J LeonP J Neumann
Apr 8, 1999·Journal of Psychosomatic Research·W S ShawI Grant
May 16, 2000·Journal of the American Geriatrics Society·G E SmithP C O'Brien
Oct 30, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·R HébertC Cohen
Dec 19, 2001·International Journal of Geriatric Psychiatry·N SpruytteF Lammertyn
Aug 20, 2003·Archives of Neurology·Liesi E HebertDenis A Evans
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Nov 6, 2003·Psychological Bulletin·Peter P VitalianoJames M Scanlan
Feb 14, 2004·Journal of the American Geriatrics Society·Joseph E GauglerRobert C Newcomer
Sep 29, 2004·Health Affairs·David C GrabowskiVincent Mor
Nov 20, 2004·Social Science & Medicine·Viviane Dias Lima, Jacek A Kopec
May 12, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Gary NaglieMurray Krahn
Oct 13, 2006·The New England Journal of Medicine·Lon S SchneiderUNKNOWN CATIE-AD Study Group
Nov 7, 2007·Archives of General Psychiatry·Robert A RosenheckUNKNOWN Clinical Antipsychotic Trial of Intervention Effectiveness-Alzheimer's Disease (CATIE-AD) investigators
May 21, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Edward Alan MillerRobert A Rosenheck
Jul 4, 2008·Archives of Gerontology and Geriatrics·Stephanie CarreteroVicente Sanjosé
Jul 31, 2008·Medical Care·Tzu-Chun KuoArlene S Ash
Nov 4, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Mary Sherman MittelmanAlistair Burns
Nov 19, 2008·International Journal of Geriatric Psychiatry·Edward Alan MillerRobert A Rosenheck

❮ Previous
Next ❯

Citations

Dec 18, 2013·International Journal of Geriatric Psychiatry·David LoweryJames Warner
Sep 1, 2015·Psychiatry Research·Hongbo HeYanling Zhou
Dec 10, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Crystal V Flynn LongmireUNKNOWN DIADS-2 Research Group
May 12, 2011·International Journal of Geriatric Psychiatry·Edward Alan MillerLon S Schneider

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.